These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Calcium-entry blockers-induced parkinsonism: possible role of inherited susceptibility. Negrotti A, Calzetti S, Sasso E. Neurotoxicology; 1992; 13(1):261-4. PubMed ID: 1508427 [Abstract] [Full Text] [Related]
6. Iatrogenic parkinsonism: the role of flunarizine and cinnarizine. Miguel R, Correia AS, Bugalho P. J Parkinsons Dis; 2014; 4(4):645-9. PubMed ID: 25125483 [Abstract] [Full Text] [Related]
8. Permanent non-progressive cinnarizine and flunarizine-induced parkinsonism: An under-recognized tardive syndrome in the elderly? Calzetti S, Negrotti A. J Neurol Sci; 2023 Jan 15; 444():120526. PubMed ID: 36584558 [Abstract] [Full Text] [Related]
9. Parkinsonism, tremor, and depression induced by cinnarizine and flunarizine. Capellà D, Laporte JR, Castel JM, Tristán C, Cos A, Morales-Olivas FJ. BMJ; 1988 Sep 17; 297(6650):722-3. PubMed ID: 3147743 [No Abstract] [Full Text] [Related]
10. [Parkinsonism due to the medication]. Louter M, Tromp SC. Ned Tijdschr Geneeskd; 2009 Sep 17; 153():A336. PubMed ID: 19900308 [Abstract] [Full Text] [Related]
11. Flunarizine- and cinnarizine-induced extrapyramidal reactions. Micheli F, Pardal MF, Gatto M, Torres M, Paradiso G, Parera IC, Giannaula R. Neurology; 1987 May 17; 37(5):881-4. PubMed ID: 3574697 [Abstract] [Full Text] [Related]
12. [Drug-induced or aggravated parkinsonism: clinical signs and the changing pattern of implicated drugs]. Martí Massó JF, Poza JJ. Neurologia; 1996 Jan 17; 11(1):10-5. PubMed ID: 8714170 [Abstract] [Full Text] [Related]
16. [Parkinsonism, depression and akathisia induced by flunarizine, a calcium entry blockade--report of 31 cases]. Kuzuhara S, Kohara N, Ohkawa Y, Fuse S, Yamanouchi H. Rinsho Shinkeigaku; 1989 Jun 17; 29(6):681-6. PubMed ID: 2582681 [Abstract] [Full Text] [Related]
17. Flunarizine and cinnarizine inhibit mitochondrial complexes I and II: possible implication for parkinsonism. Veitch K, Hue L. Mol Pharmacol; 1994 Jan 17; 45(1):158-63. PubMed ID: 8302275 [Abstract] [Full Text] [Related]